The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2019

Filed:

Aug. 22, 2017
Applicant:

Mucodel Pharma Llc, Greensboro, NC (US);

Inventor:

Madhu Hariharan, Greensboro, NC (US);

Assignee:

MUCODEL PHARMA LLC, Greensboro, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/485 (2006.01); A61M 5/19 (2006.01); A61K 6/08 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 9/107 (2006.01); A61K 31/407 (2006.01); A61K 31/5513 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01); A61K 47/02 (2006.01); A61K 45/06 (2006.01); A61K 47/12 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/006 (2013.01); A61K 9/0043 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 9/107 (2013.01); A61K 9/1075 (2013.01); A61K 31/407 (2013.01); A61K 31/485 (2013.01); A61K 31/5513 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A61K 47/38 (2013.01); A61M 5/19 (2013.01);
Abstract

A kit for mucosally administering a metastable supersaturated solution of a pharmaceutical active agent to a human patient includes a first compartment comprising a first composition comprising a pharmaceutical active agent in solution at or below equilibrium solubility, and a second composition comprising an acidic buffer. The first and second compartments maintain separation of the first and second compositions during storage, and allow for mixing of the first and second compositions to form a supersaturated solution above equilibrium solubility of the pharmaceutical active agent for immediate mucosal administration to a human patient. In one embodiment, the second composition comprises an acidic buffer and the supersaturated solution has an acidic pH. Alternatively, the second composition comprises a basic buffer and the supersaturated solution has a basic pH.


Find Patent Forward Citations

Loading…